Sanderling Venture Partners VI LP
CIK 0001306717 Name as filed on the most recent filing
Filed as Sanderling Venture Partners VI LP (9)
42 transaction lines · from 9 filings · filed 2011-02-10 to 2024-11-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-11-01 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 86,867 acquired | 3.75 | 325,751.25 | Form 4, filing 0001415889-24-026103 | |
| 2024-11-01 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 877 acquired | 3.75 | 3,288.75 | Form 4, filing 0001415889-24-026103 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 243,356 acquired | 3.70 | 900,903.91 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 194,472 acquired | 3.70 | 719,935.34 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 144,676 acquired | 3.70 | 535,590.55 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 51,032 acquired | 3.70 | 188,920.46 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 28,744 acquired | 3.70 | 106,410.29 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 13,184 acquired | 3.70 | 48,807.17 | Form 4, filing 0001415889-24-001830 | |
| 2024-01-23 |
CalciMedica, Inc. CALC |
P, Open-market purchase | 3,920 acquired | 3.70 | 14,511.84 | Form 4, filing 0001415889-24-001830 | |
| 2013-03-19 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 46,339 disposed | 26.95 | 1,248,836.05 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-19 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 38,250 disposed | 27.66 | 1,057,995.00 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 29,825 disposed | 28.19 | 840,766.75 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 29,415 disposed | 28.19 | 829,208.85 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 28,956 disposed | 29.20 | 845,515.20 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 28,558 disposed | 29.20 | 833,893.60 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 24,688 disposed | 28.19 | 695,954.72 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-18 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 23,969 disposed | 29.20 | 699,894.80 | Form 4, filing 0001104659-13-022694 | |
| 2013-03-11 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 348,951 disposed | 27.86 | 9,721,774.86 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-11 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 348,951 disposed | 27.86 | 9,721,774.86 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 10,407 disposed | 25.92 | 269,749.44 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 438 disposed | 25.92 | 11,352.96 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 368 disposed | 25.92 | 9,538.56 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 10,485 disposed | 25.92 | 271,771.20 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 1,852 disposed | 25.92 | 48,003.84 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 78 disposed | 25.92 | 2,021.76 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 66 disposed | 25.92 | 1,710.72 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 1,866 disposed | 25.92 | 48,366.72 | Form 4, filing 0001104659-13-029502 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 10,485 disposed | 25.92 | 271,771.20 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 10,407 disposed | 25.92 | 269,749.44 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 1,866 disposed | 25.92 | 48,366.72 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 1,852 disposed | 25.92 | 48,003.84 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 438 disposed | 25.92 | 11,352.96 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 368 disposed | 25.92 | 9,538.56 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 78 disposed | 25.92 | 2,021.76 | Form 4, filing 0001104659-13-019400 | |
| 2013-03-07 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 66 disposed | 25.92 | 1,710.72 | Form 4, filing 0001104659-13-019400 | |
| 2013-01-24 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 500,000 disposed | 18.93 | 9,465,000.00 | Form 4, filing 0001104659-13-029501 | |
| 2013-01-24 |
Pacira Pharmaceuticals, Inc. PCRX |
S, Open-market sale | 500,000 disposed | 18.93 | 9,465,000.00 | Form 4, filing 0001104659-13-004737 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 46,379 acquired | 7.00 | 324,653.00 | Form 4, filing 0001181431-11-009279 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 184,131 acquired | 7.00 | 1,288,917.00 | Form 4, filing 0001181431-11-009280 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 27,931 acquired | 7.00 | 195,517.00 | Form 4, filing 0001181431-11-009280 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 5,119 acquired | 7.00 | 35,833.00 | Form 4, filing 0001181431-11-009280 | |
| 2011-02-08 |
Pacira Pharmaceuticals, Inc. PCRX |
P, Open-market purchase | 4,297 acquired | 7.00 | 30,079.00 | Form 4, filing 0001181431-11-009280 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Sanderling Venture Partners VI LP, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001306717
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6